RxDoctor Payments Data

Andrew Alloy

Gastroenterology · Voorhees, NJNPI 1275533036

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 606 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 42.1% of the total. Reporting peaked in 2021 at $2,426 and has fallen 99.4% since, to $15 in 2023.

$6,525in general payments, 2019–2025

Across 606 payments — averaging $10.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$686
  • Johnson & Johnson$476
  • QOL Medical, LLC$455
  • Bristol Myers Squibb$277
  • plus $782 from 16 others

What the payments were for

  • Food & beverage$6,41998%
  • Education$1062%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,525 in reported general payments places this provider in the 75th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey →

Other gastroenterology in Voorhees

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →